Cc. Yan et Rj. Huxtable, EFFECTS OF TAURINE AND GUANIDINOETHANE SULFONATE ON TOXICITY OF THE PYRROLIZIDINE ALKALOID MONOCROTALINE, Biochemical pharmacology, 51(3), 1996, pp. 321-329
Monocrotaline (MONO), a pyrrolizidine alkaloid, causes pulmonary arter
ial hypertension and right ventricular hypertrophy due to hepatic meta
bolism to the alkylating pyrrole dehydromonocrotaline. Taurine, a sulf
onic amino acid, is hepato- and cardioprotective in a variety of condi
tions. We have examined the effects of taurine and its amidino analog,
guanidinoethane sulfonate (GES), in rats injected i.p. with MONO (65
mg/kg). Taurine and GES were given as 1% solutions in drinking water b
eginning 14 days before administration of MONO and continuing for 14 d
ays thereafter, when the rats were killed. The MONO group had right ve
ntricular hypertrophy and pulmonary hyperplasia. Compared with control
, no significant changes in the right ventricle/left ventricle weight
ratio, or the right ventricle/body weight ratio occurred in rats also
given taurine or GES. Lung weights in these two groups were higher tha
n in the control group, but below that of the MONO-alone group. The le
thality of MONO over 14 days was decreased by taurine (LD(50) for MONO
alone 80 mg/kg; for MONO + taurine 121 mg/kg). Rats given only MONO h
ad lower hepatic concentrations of GSH and cysteine (Cys), and higher
activities of microsomal GSH transferase and gamma-glutamyl transpepti
dase. In rats also receiving taurine, hepatic GSH levels and GSH trans
ferase activity were no different from control. gamma-Glutamylcysteine
(Glu-Cys) synthetase and gamma-glutamyl transpeptidase activities wer
e elevated. In MONO-injected rats given GES, hepatic GSH levels were h
igher and Cys levels were lower than in either the MONO alone or MONO
+ taurine groups. gamma-Glu-Cys synthetase activity was depressed. Mic
rosomal GSH transferase, GSH peroxidase and gamma-glutamyl transpeptid
ase activities were elevated. Livers of MONO-injected animals showed h
igher levels of serine (reversed by both taurine and GES) and glycine
(Gly; reversed by GES) and lower levels of glutamine. Compared with co
ntrol rats, the following changes occurred in serum amino acids: MONO
alone: increased aspartate, taurine and lysine; taurine-supplemented:
increased taurine, methionine (Met) and lysine, and decreased Gly; GES
-supplemented: decreased asparagine, serine, Gly, arginine, taurine, a
nd valine. Compared with the MONO-alone group, the taurine-supplemente
d group had higher glutamate (Glu), Met and alanine, and the GES-suppl
emented group higher alanine and lower serine, Gly, arginine and valin
e. We conclude that taurine protects against MONO-induced lethality an
d right ventricular hypertrophy. GES also protects against right ventr
icular hypertrophy. However, these agents act by different mechanisms,
taurine preventing many of the biochemical changes induced by MONO, w
ith GES inducing additional changes.